OneSource Connect was developed by Quantum Leap Healthcare Collaborative (QLHC) as a strategic initiative to streamline the capture of clinical and research data at the point-of-care from Electronic Health Records (EHR) systems for secondary uses, such as clinical trials and registries.
OneSource is the only integrated EHR/electronic data capture (EDC) solution that captures regulatory-grade data from Epic and Cerner EHRs with both Clinical Research Coordinator (CRC) and patient-mediated data access. The platform includes best-in-class solutions for electronic data capture (EDC), electronic patient reported outcomes (ePRO), biospecimen, trial randomization, safety reporting and site payment systems that are fully integrated.
Data capture, cleaning and validation represent a considerable portion of the costs of conducting clinical trials. Manual data abstraction from electronic health records to trial-specific electronic case report forms is time consuming and error-prone; the associated costs and staffing requirements also represent a significant barrier for clinical sites to participate in clinical trial enrollment. Recent developments, including the emergence of modern clinical trial designs that require rapid access to study data and the urgency of public health crises such as the COVID-19 pandemic have underscored the need to re-engineer current data capture and management approaches and tools for clinical trials.
The OneSource Connect platform is currently deployed at over 25 sites participating in the multicenter, phase 2 I-SPY 2 TRIAL and I-SPY-COVID-19 adaptive platform trial. Data auto-captured from these sites has led to data entry efficiencies and downstream cost savings in cleaning and source data verification (SDV). OneSource has the additional benefits of low implementation times and reusability across sites compared to other EHR integration approaches.
For more information on how OneSource Connect can be leveraged for your clinical trial or research network. Please reach out to Adam Asare, Chief Data Officer, at aasare@quantumleaphealth.org
OneSource AI provides access to secure analytic workspaces and data for partners to explore and develop models and AI algorithms leveraging data from the I-SPY family of trials. Datasets include clinical, imaging, biomarker and sequencing data.
Full end-to-end platform services for that study to happen inside the environment. OneSource AI’s platform houses over 7,000 H & E image files used by pathologists to collaboratively review whole slide images (WSI) and share their findings in real-time. Ee-identified images are available for wider use to researchers across healthcare, academia, and industry to carry out novel research in a secure and audited environment. Leveraging the benefits of cloud computing, this enables researchers to have real-time access to a secure and scalable platform that can help them to manage and analyze large amounts of data more efficiently.
OneSource AI plays a pivotal role in enabling novel AI/ML research to identify patterns and trends in the data that may not be immediately apparent. The platform supports researchers in making more accurate predictions about the efficacy of different treatments and therapies, which can ultimately lead to better outcomes for patients.
OneSource AI has the potential to revolutionize medical research by providing researchers with access to a wealth of data and advanced analytics tools that can help them to identify new treatments and therapies more effectively and collaboratively than ever before.
For more information on how OneSource AI can help with analytical modeling and AI algorithm development leveraging data from the I-SPY family of trials p lease reach out to Adam Asare, Chief Data Officer, at aasare@quantumleaphealth.org
